EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications

Priyanka Singh iD, Santosh Pandit iD, Sri Renukadevi Balusamy, Mukil Madhusudanan, Hina Singh, H Mohamed Amsath Haseef, Ivan Mijakovic

Advanced Healthcare Materials · 2025-02 · 14 (4)

DOI: 10.1002/adhm.202403059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 06.11.2024. Verfasst von Priyanka Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation, Center for Biosustainability, Technical University of Denmark, Kogens Lyngby, DK-2800, Denmark. Hauptthemen laut MEDLINE: Neoplasms, Gold, Silver, Metal Nanoparticles. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 450 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NordForsk, Danmarks Frie Forskningsfond, Novo Nordisk Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains one of the most challenging health issues globally, demanding innovative therapeutic approaches for effective treatment. Nanoparticles, particularly those composed of gold, silver, and iron oxide, have emerged as promising candidates for changing cancer therapy. This comprehensive review demonstrates the landscape of nanoparticle‐based oncological interventions, focusing on the remarkable advancements and therapeutic potentials of gold, silver, and iron oxide nanoparticles. Gold nanoparticles have garnered significant attention for their exceptional biocompatibility, tunable surface chemistry, and distinctive optical properties, rendering them ideal candidates for various cancer diagnostic and therapeutic strategies. Silver nanoparticles, renowned for their antimicrobial properties, exhibit remarkable potential in cancer therapy through multiple mechanisms, including apoptosis induction, angiogenesis inhibition, and drug delivery enhancement. With their magnetic properties and biocompatibility, iron oxide nanoparticles offer unique cancer diagnosis and targeted therapy opportunities. This review critically examines the recent advancements in the synthesis, functionalization, and biomedical applications of these nanoparticles in cancer therapy. Moreover, the challenges are discussed, including toxicity concerns, immunogenicity, and translational barriers, and ongoing efforts to overcome these hurdles are highlighted. Finally, insights into the future directions of nanoparticle‐based cancer therapy and regulatory considerations, are provided aiming to accelerate the translation of these promising technologies from bench to bedside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGoldSilverMetal NanoparticlesFerric CompoundsMagnetic Iron Oxide NanoparticlesHumansAnimals

Stichwörter der Autor:innen

cancer therapycombination therapydiagnosticdrug deliverygold nanoparticlesimaging, iron oxide nanoparticlesmetallic nanoparticlespersonalized medicinesilver nanoparticles

Substanzen

GoldSilverFerric Compoundsferric oxide

Autor:innen und Institutionen

  • The Novo Nordisk Foundation, Center for Biosustainability, Technical University of Denmark, Kogens Lyngby, DK-2800, Denmark.
  • Systems and Synthetic Biology Division, Department of Life Sciences, Chalmers University of Technology, Gothenburg, SE-412 96, Sweden.
  • Department of Food Science and Biotechnology, Sejong University, Gwangjin-Gu, Seoul, 05006, Republic of Korea.
  • Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA, 92521, USA.
  • Faculty of Engineering Science, KU Leuven, Leuven, 3000, Belgium.

ORCID-Profile: Priyanka Singh, Santosh Pandit

Förderung

  • NordForsk
  • Danmarks Frie Forskningsfond
  • Novo Nordisk Pharma
  • Lundbeck Foundation

Zitieren

APA

Singh, P., Pandit, S., Balusamy, S. R., Madhusudanan, M., Singh, H., Amsath Haseef, H. M., & Mijakovic, I. (2025). Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications. Advanced Healthcare Materials, 14(4). https://doi.org/10.1002/adhm.202403059

Vancouver

Singh P, Pandit S, Balusamy SR, Madhusudanan M, Singh H, Amsath Haseef HM, et al. Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications. Advanced Healthcare Materials. 2025;14(4). doi:10.1002/adhm.202403059

BibTeX
@article{Singh2025,
  author = {Singh, Priyanka and Pandit, Santosh and Balusamy, Sri Renukadevi and Madhusudanan, Mukil and Singh, Hina and Amsath Haseef, H Mohamed and Mijakovic, Ivan},
  title = {Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {4},
  doi = {10.1002/adhm.202403059}
}
Kostenlos starten →